Evidence map›Paper›PMID 31881056›Full record

ArticlePloS one2019

Fast and accurate quantification of insertion-site specific transgene levels from raw seed samples using solid-state nanopore technology.

Michael D Pearson, Leslee Nguyen, Yanan Zhao, William L McKenna, Trevor J Morin, William B Dunbar

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Michael D PearsonOntera, Inc., Santa Cruz, California, United States of America.ORCID 0000-0002-1047-8572
Leslee NguyenOntera, Inc., Santa Cruz, California, United States of America.ORCID 0000-0002-6750-4575
Yanan ZhaoOntera, Inc., Santa Cruz, California, United States of America.ORCID 0000-0002-9909-5980
William L McKennaOntera, Inc., Santa Cruz, California, United States of America.
Trevor J MorinOntera, Inc., Santa Cruz, California, United States of America.
William B DunbarOntera, Inc., Santa Cruz, California, United States of America.ORCID 0000-0002-0913-318X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many modern crop varieties contain patented biotechnology traits, and an increasing number of these crops have multiple (stacked) traits. Fast and accurate determination of transgene levels is advantageous for a variety of use cases across the food, feed and fuel value chain. With the growing number of new transgenic crops, any technology used to quantify them should have robust assays that are simple to design and optimize, thereby facilitating the addition of new traits to an assay. Here we describe a PCR-based method that is simple to design, starts from whole seeds, and can be run to end-point in less than 5 minutes. Subsequent relative quantification (trait vs. non-trait) using capillary electrophoresis performed in 5% increments across the 0-100% range showed a mean absolute error of 1.9% (s.d. = 1.1%). We also show that the PCR assay can be coupled to non-optical solid-state nanopore sensors to give seed-to-trait quantification results with a mean absolute error of 2.3% (s.d. = 1.6%). In concert, the fast PCR and nanopore sensing stages demonstrated here can be fully integrated to produce seed-to-trait quantification results in less than 10 minutes, with high accuracy across the full dynamic range.

Indexed as

TransgenesCrops, AgriculturalDNA, PlantElectrophoresis, CapillaryGlycine maxNanoporesPlants, Genetically ModifiedPolymerase Chain ReactionQuantitative Trait, HeritableSeedsTime FactorsDNA, Plant

Identifiers

PMID31881056
PMCPMC6934305
OpenAlexW2998707832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.